Literature DB >> 23025542

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.

Carolina Ferraz1, Christian Rehfeld, Annelise Krogdahl, Eva Magrethe Precht Jensen, Eileen Bösenberg, Frank Narz, Laszlo Hegedüs, Ralf Paschke, Markus Eszlinger.   

Abstract

BACKGROUND: The diagnostic limitations of fine needle aspiration (FNA), like the indeterminate category, can be partially overcome by molecular analysis. As PAX8/PPARG and RET/PTC rearrangements have been detected in follicular thyroid carcinomas (FTCs) and papillary thyroid carcinomas (PTCs), their detection in FNA smears could improve the FNA diagnosis. To date, these rearrangements have never been analyzed in routine air-dried FNA smears, but only in frozen tissue, formalin-fixed paraffin-embedded (FFPE) tissue, and in fresh FNA material. Fixed routine air-dried FNA samples have hitherto been judged as generally not suitable for testing these rearrangements in a clinical setting. Therefore, the objective of the present study was to investigate the feasibility of extracting RNA from routine air-dried FNA smears for the detection of these rearrangements with real-time polymerase chain reaction (RT-PCR).
METHODS: A new method for RNA extraction from routine air-dried FNA smears was established, which allowed analysis for the presence of four variants of PAX8/PPARG and RET/PTC 1 and RET/PTC 3, which were analyzed in 106 routine FNA smears and the corresponding surgically obtained FFPE tissues using real-time quantitative PCR (RT-qPCR). To assess RNA quality, an intron-spanning PAX8 cDNA was amplified.
RESULTS: Acceptable RNA quality was obtained from 95% of the FNA samples and 92% of the FFPE samples. PAX8/PPARG was detected in 4 of 96 FFPEs and in 6 of 96 FNAs. PAX8/PPARG was present in 4 of 10 FTCs and in 3 of 42 follicular adenomas (FAs). Similarly, RET/PTC was found in 3 of 96 FFPEs and in 4 of 96 FNAs. Two of 21 PTC samples and 3 of 42 FA samples carried this rearrangement.
CONCLUSION: These data are the first to show the feasibility of extracting RNA from routine air-dried FNA smears for the detection of PAX8/PPARG and RET/PTC rearrangements with RT-qPCR. These promising methodological advances, if confirmed in larger series of FNA and FFPE samples, may lead to the introduction of molecular analysis of routine air-dried FNA smears in everyday practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23025542      PMCID: PMC3462388          DOI: 10.1089/thy.2011.0391

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  26 in total

1.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

2.  Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

Authors:  Zhaowen Zhu; Raffaele Ciampi; Marina N Nikiforova; Manoj Gandhi; Yuri E Nikiforov
Journal:  J Clin Endocrinol Metab       Date:  2006-06-13       Impact factor: 5.958

3.  Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.

Authors:  Silvia Cantara; Marco Capezzone; Stefania Marchisotta; Serena Capuano; Giulia Busonero; Paolo Toti; Andrea Di Santo; Giuseppe Caruso; Anton Ferdinando Carli; Lucia Brilli; Annalisa Montanaro; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2010-02-03       Impact factor: 5.958

4.  Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.

Authors:  Ana Rita Marques; Carla Espadinha; Ana L Catarino; Sónia Moniz; Teresa Pereira; Luís G Sobrinho; Valeriano Leite
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

5.  PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Authors:  Marina N Nikiforova; Paul W Biddinger; Christy M Caudill; Todd G Kroll; Yuri E Nikiforov
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

Review 6.  Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.

Authors:  Markus Eszlinger; Ralf Paschke
Journal:  Mol Cell Endocrinol       Date:  2010-01-18       Impact factor: 4.102

7.  Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.

Authors:  Alicia Algeciras-Schimnich; Dragana Milosevic; Bryan McIver; Heather Flynn; Honey V Reddi; Norman L Eberhardt; Stefan K G Grebe
Journal:  Clin Chem       Date:  2010-01-07       Impact factor: 8.327

8.  Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas.

Authors:  Kristian Unger; Horst Zitzelsberger; Giuliana Salvatore; Massimo Santoro; Tatjana Bogdanova; Herbert Braselmann; Peter Kastner; Lyudmilla Zurnadzhy; Nikolay Tronko; Peter Hutzler; Gerry Thomas
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

9.  Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.

Authors:  Giuliana Salvatore; Riccardo Giannini; Pinuccia Faviana; Alessia Caleo; Ilenia Migliaccio; James A Fagin; Yuri E Nikiforov; Giancarlo Troncone; Lucio Palombini; Fulvio Basolo; Massimo Santoro
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

10.  The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer.

Authors:  Kimberly A Placzkowski; Honey V Reddi; Stefan K G Grebe; Norman L Eberhardt; Bryan McIver
Journal:  PPAR Res       Date:  2008-10-29       Impact factor: 4.964

View more
  11 in total

1.  Hürthle Cells Adenoma of the Thyroid with Post-surgical Implants in the Neck: Clinical, Morphological, and Molecular Analysis of Three Cases.

Authors:  Massimo Bongiovanni; Silvia Uccella; Luca Giovanella; Francesca Molinari; Milo Frattini; Gianlorenzo Dionigi; Eliana Piantanida; Antoine Nobile; Fausto Sessa; Stefano La Rosa
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

Review 2.  Molecular profiling of thyroid nodule fine-needle aspiration cytology.

Authors:  Markus Eszlinger; Lorraine Lau; Sana Ghaznavi; Christopher Symonds; Shamir P Chandarana; Moosa Khalil; Ralf Paschke
Journal:  Nat Rev Endocrinol       Date:  2017-03-31       Impact factor: 43.330

3.  Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.

Authors:  Tomasz Stokowy; Bartosz Wojtas; Barbara Jarzab; Knut Krohn; David Fredman; Henning Dralle; Thomas Musholt; Steffen Hauptmann; Dariusz Lange; László Hegedüs; Ralf Paschke; Markus Eszlinger
Journal:  Endocrine       Date:  2016-07-29       Impact factor: 3.633

Review 4.  Molecular testing in the diagnosis of differentiated thyroid carcinomas.

Authors:  Silvia Martina Ferrari; Poupak Fallahi; Ilaria Ruffilli; Giusy Elia; Francesca Ragusa; Sabrina Rosaria Paparo; Salvatore Ulisse; Enke Baldini; Riccardo Giannini; Paolo Miccoli; Alessandro Antonelli; Fulvio Basolo
Journal:  Gland Surg       Date:  2018-08

5.  FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.

Authors:  Amanda L Treece; Nathan D Montgomery; Nirali M Patel; Chris J Civalier; Leslie G Dodd; Margaret L Gulley; Jessica K Booker; Karen E Weck
Journal:  Cancer Cytopathol       Date:  2016-02-16       Impact factor: 5.284

6.  Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.

Authors:  Poupak Fallahi; Riccardo Giannini; Paolo Miccoli; Alessandro Antonelli; Fulvio Basolo
Journal:  Curr Genomics       Date:  2014-06       Impact factor: 2.236

7.  Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison.

Authors:  L Giovanella; A Campenni; G Treglia; F A Verburg; P Trimboli; L Ceriani; M Bongiovanni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-23       Impact factor: 9.236

8.  Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens.

Authors:  Young Sin Ko; Tae Sook Hwang; Ja Yeon Kim; Yoon-La Choi; Seung Eun Lee; Hye Seung Han; Wan Seop Kim; Suk Kyeong Kim; Kyoung Sik Park
Journal:  Int J Mol Sci       Date:  2017-04-12       Impact factor: 5.923

9.  Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.

Authors:  Whitney S Goldner; Trevor E Angell; Sallie Lou McAdoo; Joshua Babiarz; Peter M Sadow; Fadi A Nabhan; Christian Nasr; Richard T Kloos
Journal:  Thyroid       Date:  2019-09-27       Impact factor: 6.568

10.  Impact of ultrasonographic features, cytomorphology and mutational testing on malignant and indeterminate thyroid nodules on diagnostic accuracy of fine needle cytology samples: A prospective analysis of 141 patients.

Authors:  Franco Fulciniti; Anna Cipolletta Campanile; Maria Gabriella Malzone; Maria Grazia Chiofalo; Anna Capiluongo; Mario Monaco; Nunzia Di Maio; Fabio Sandomenico; Gerardo Botti; Gennaro Chiappetta; Emilia Vuttariello; Luciano Pezzullo
Journal:  Clin Endocrinol (Oxf)       Date:  2019-10-01       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.